Starpharma Holdings Limited
SPHRY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,299 | -$5,392 | -$7,131 | -$517 |
| Dep. & Amort. | $266 | $539 | $546 | $569 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $436 | $0 | $1,466 | $0 |
| Change in WC | $1,221 | $0 | $2,230 | $0 |
| Other Non-Cash | -$2,005 | $3,855 | -$6,186 | $2,046 |
| Operating Cash Flow | -$2,382 | -$998 | -$9,075 | $2,098 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6 | -$16 | -$80 | -$9 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$6 | -$16 | -$80 | -$9 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$39 | -$525 | $396 | -$5,143 |
| Financing Cash Flow | -$39 | -$525 | $396 | -$5,143 |
| Forex Effect | -$9 | -$3 | -$12 | $3 |
| Net Chg. in Cash | $0 | $20,277 | -$8,771 | -$3,049 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $32,131 | $35,180 |
| End Cash | $0 | $0 | $23,360 | $32,131 |
| Free Cash Flow | -$2,387 | -$1,014 | -$9,155 | $2,089 |